Streetbeat News

Stock Prices

ENLV

Enlivex shares are trading lower following the announcement of topline results from its Phase II trial evaluating Allocetra in sepsis.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 1:08 pm

GL

Globe Life (GL) shares dropped following a report by Fuzzy Panda Research, alleging extensive insurance fraud within the company. The report claims that sales agencies involved in over $200 million of AIL's ALP, constituting more than 60% of AIL's new business, engaged in fraudulent activities such as writing policies for deceased or fictitious individuals, forging customer signatures, unauthorized bank withdrawals, and actuarial fraud. Additionally, it alleges illegal kickbacks to Globe Life executives exceeding $65 million.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 1:04 pm

HOOD

Citigroup analyst Christopher Allen downgraded Robinhood Markets (HOOD) from Neutral to Sell, while raising the price target from $13 to $16.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 1:01 pm

DASH

DoorDash shares are trading higher following an upgrade from Neutral to Buy by MoffettNathanson.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 1:01 pm

ALPN

VRTX

Vertex Pharmaceuticals Incorporated (VRTX) is set to acquire Alpine Immune Sciences Inc (ALPN) for approximately $4.9 billion, or $65 per share, in cash. This acquisition aims to expand Vertex's portfolio beyond its cystic fibrosis franchise into kidney disease treatments, with Alpine's lead molecule, povetacicept (ALPN-303), showing promise in IgA nephropathy (IgAN). The deal, expected to close in Q2 2024, aligns with Vertex's strategy of targeting diseases with high unmet need. Alpine's recent Phase 1b/2a study of povetacicept reported significant reductions in proteinuria and hematuria in IgAN patients.

Portfolio Pulse from Vandana Singh

April 11, 2024 | 1:01 pm

AMZN

Amazon has appointed Andrew Ng, a prominent figure in artificial intelligence, to its Board of Directors. This move signifies Amazon's commitment to advancing its AI capabilities, leveraging Ng's extensive experience in the field.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 1:01 pm

WCC

Recent analyst evaluations of WESCO Intl (NYSE:WCC) show a mix of bullish and indifferent sentiments, with 6 somewhat bullish and 2 indifferent ratings in the last three months. The average 12-month price target for WCC has been adjusted to $176.38, marking a 4.66% decrease from the previous target of $185.00. Analysts from firms like Keybanc, JP Morgan, Oppenheimer, Baird, and RBC Capital have updated their ratings and price targets, reflecting a nuanced view of WCC's market performance and financial health. Despite facing revenue growth challenges and below-average profitability metrics, WESCO Intl's strategic positioning and analyst attention suggest a cautiously optimistic outlook.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 1:01 pm

COLL

Collegium Pharmaceutical (NASDAQ:COLL) has received mixed analyst ratings over the past three months, with a recent upward trend in price targets to an average of $39.75, indicating a 7.43% increase from the previous $37.00. Analysts from Needham, Truist Securities, and Piper Sandler have maintained or raised their ratings, reflecting positive market dynamics and company performance. Collegium's financial performance shows strong revenue growth, profitability, and efficient asset management, with a market capitalization below industry averages but impressive growth and net margins.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 1:00 pm

GEN

Barclays analyst Saket Kalia downgraded Gen Digital (NASDAQ:GEN) from Overweight to Equal-Weight and reduced the price target from $28 to $25, indicating a more cautious outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 12:57 pm

SMSI

Trading for SMSI was halted and then resumed at 8:55:00 AM ET, with updates on quotation resumption, news, and resumption times provided.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 12:55 pm